Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1054_Библиотеки_им_академика_М_И_Перельмана
.pdf
176
https://t.me/medicina_free
23.6.6 Case 6: EO withDual Flap
forMulticentric Disease
C. Koppiker et al.
a
d
g
(a) Pre-operative Markings (b) Excision Planning for
LICAP Flap and MICAP ap (c-d) Intraoperative LICAP
and MICAP ap respectively (Excision size: 5×5×3cm
b c
e
h i
f
and 8.8×8×4.1cm; 75cc and 288.64cc) (e) The Larger
Specimen (f-g) Post-operative (Immediate) (h-i) Postoperative (after 2years)
A 44-year-old female patient presented two irregular spiculated masses in right breast at 3 o’clock
2B position (2.37 × 1.76 cm)and 9 o’clock 2B
position (2.76 × 1.6 cm) – multicentric disease
also with suspicious right axillary lymph node.
Trucut Biopsy of both the lesions revealed IDC
Grade II.ER: 95%, PR: 95%, HER2: Negative.
Post-NAHT tumour sizes reduced to –
1.66×0.92cm and 1.98×1.14cm. Patient then
underwent excision of both lumps and reconstruction with LICAP and MICAP with Sentinel
node biopsy HPE revealed IDC Grade II+DCIS,
9 o’clock had multiple foci of invasive carcinoma
the largest one being 3.7× 3.3 ×1.9cm in size
and satellite focus was 0.2cm in size (DCIS was
20% of the volume) (closest margin 0.4cm). 3 o’
clock lesion showed 5% DCIS (closest margin
0.5cm) with tumour size 1.9×1.8×0.9cm. SLN
status: 2/8, clinical staging pT2N1M0. Patient
received RT and hormonal therapy and is alive
and well at 2years.

a
Medial Pillar
23 Extreme Oncoplasty inBreast Reconstruction
https://t.me/medicina_free
23.6.7 Case 7: Benign Pseudoangiomatous Stromal
Hyperplasia
177
Lateral pillar with
Latero central
pedicle
bi
bii
Inferior pedicle having some
PA SH - pseudo angiomatous stromal hyperplasia
breast tissue
cd
(a) Large Left breast presented with Pseudo- angiomatous
Stromal Hyperplasia (PASH). (bi) and (bii) MRI showing
the benign PASH in the breast. (c) Post-op image after the
A 28-year-old female presented with a complaint
of huge left breast enlargement. Trucut biopsy of
the lesion of the left breast showed a benign
Pseudo-angiomatous Stromal Hyperplasia
(PASH). The size of the lesion reported on MRI
was 17.0 × 15.5 × 17.1 cm (4505.85 cc). The
patient underwent breast conservation using an
extreme therapeutic mammoplasty of the left
breast. Histopathological analysis conrmed the
presence of a benign Pseudo-angiomatous
Stromal Hyperplasia. After 10years she remains
extreme oncoplastic procedure. (d) 3-year follow-up after
the surgery
well. She lactated from the right breast with minimal lactation from the left side.
Acknowledgement The author would like to thank all
participants who consented to participate in this Chapter.
I, acknowledge Bajaj Auto Ltd. for providing support to
research activities at Prashanti Cancer Care Mission,
Pune.
I am thankful to, Dr. Sneha Joshi, Dr. Sanket Nagarkar,
Dr. Santosh Dixit, Dr. Rupa Mishra, Ms. Smeeta Nare, Dr.
Nutan Gangurde Ms. Shaheen Shaikh and Ms. Laleh
Busheri for their support in the preparation of this book
chapter.

178
https://t.me/medicina_free
C. Koppiker et al.
References
1. Rose M, Svensson H, Handler J, Hoyer U, Ringberg
A, Manjer J. Patient-reported outcome after oncoplastic breast surgery compared with conventional
breast-conserving surgery in breast cancer. Breast
Cancer Res Treat [Internet]. 2020/01/27. 2020
Feb;180(1):247–256. Available from: https://pubmed.
ncbi.nlm.nih.gov/31989380
2. Bazzarelli A, Baker L, Petrcich W, Zhang J,
Arnaout A. Patient satisfaction following level II
Oncoplastic breast surgery: a comparison with mastectomy Utililizing the breast-Q questionnaire will
be published in surgical oncology. Surg Oncol. 2020
Dec;35:556–9.
3. Silverstein MJ.Radical mastectomy to radical conservation (extreme Oncoplasty): a revolutionary change.
J Am Coll Surg. 2016 Jan;222(1):1–9.
4. Silverstein MJ, Savalia N, Khan S, Ryan J.Extreme
oncoplasty: breast conservation for patients who need
mastectomy. Breast J. 2015;21(1):52–9.
5. Weber WP, Soysal SD, El-Tamer M, Sacchini V,
Knauer M, Tausch C, et al. First international consensus conference on standardization of oncoplastic
breast conserving surgery. Breast Cancer Res Treat.
2017 Aug;165(1):139–49.
6. Franceschini G, Terribile D, Magno S, Fabbri C,
Accetta C, Di Leone A, etal. Update on oncoplastic breast surgery. Eur Rev Med Pharmacol Sci. 2012
Oct;16(11):1530–40.
7. Franceschini G, Magno S, Fabbri C, Chiesa F, Di
Leone A, Moschella F, et al. Conservative and radical oncoplastic approches in the surgical treatment
of breast cancer. Eur Rev Med Pharmacol Sci.
2008;12(6):387–96.
8. Mock V.Body image in women treated for breast cancer. Nurs Res. 1993;42(3):153–7.
9. Türk KE, Yılmaz M.The effect on quality of life and
body image of mastectomy among breast cancer survivors. Eur J breast Heal. 2018 Oct;14(4):205–10.
10. Yerushalmi R, Tyldesley S, Woods R, Kennecke HF,
Speers C, Gelmon KA.Is breast-conserving therapy a
safe option for patients with tumor multicentricity and
multifocality? Ann Oncol. 2012 Apr;23(4):876–81.
11. Behranwala KA, Dua RS, Ross GM, Ward A, A’hern
R, Gui GPH. The inuence of radiotherapy on capsule formation and aesthetic outcome after immediate
breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg.
2006;59(10):1043–51.
12. Boughey JC, Hoskin TL, Hartmann LC, Johnson JL,
Jacobson SR, Degnim AC, etal. Impact of reconstruction and reoperation on long-term patient-reported
satisfaction after contralateral prophylactic mastectomy. Ann Surg Oncol. 2015;22(2):401–8.
13. Rocco N, Catanuto G, Cinquini M, Audretsch W,
Benson J, Criscitiello C, et al. Should oncoplastic
breast conserving surgery be used for the treatment
of early stage breast cancer? Using the GRADE
approach for development of clinical recommendations. Breast. 2021 Jun;57:25–35.
14. Franceschini G, Di Leone A, Masetti R. Comment
on “extreme Oncoplastic surgery for multifocal/multicentric and locally advanced breast cancer”. Int J
Breast Cancer. 2019;2019:4693794.
15. Koppiker CB, Noor AU, Dixit S, Busheri L, Sharan G,
Dhar U, etal. Extreme Oncoplastic surgery for multifocal/multicentric and locally advanced breast cancer.
Int J Breast Cancer. 2019;2019:4262589.
16. Crown A, Laskin R, Rocha FG, Grumley J.Extreme
oncoplasty: expanding indications for breast conservation. Am J Surg. 2019 May;217(5):851–6.
17. Acea Nebril B, García Novoa A, Polidorio N,
Cereijo Garea C, Bouzón Alejandro A, Mosquera
OJ. Extreme oncoplasty: the last opportunity for
breast conservation- analysis of its impact on survival
and quality of life. Breast J. 2019 May;25(3):535–6.
18. Savioli F, Seth S, Morrow E, Doughty J, Stallard S,
Malyon A, etal. Extreme oncoplasty: breast conservation in patients with large, multifocal, and multicentric breast cancer. Breast Cancer (Dove Med Press).
2021;13:353–9.
19. IARC Inc. Globocon India Fact Sheet 2020. In 2020.
p.2.
20. Thakur KK, Bordoloi D, Kunnumakkara
AB.Alarming burden of triple-negative breast cancer
in India. Clin Breast Cancer. 2018 Jun;18(3):e393–9.
21. Bhattacharyya GS, Doval DC, Desai CJ, Chaturvedi
H, Sharma S, Somashekhar SP. Overview of breast
cancer and implications of overtreatment of earlystage breast cancer: an Indian perspective. JCO Glob
Oncol. 2020 Jun;6:789–98.
22. Mishra V, Kelkar R, Agrawal A, Matcheswalla S.A
survey on oncoplastic breast surgery awareness and
practice patterns among indian surgeons: a crosssectional study. Int J Med Sci Diagnosis Res. 2021
Feb;5(2 SE-Articles)
23. Koppiker CB, Chintamani DS. Oncoplastic breast
surgery in India: thinking globally, acting locally.
Indian J Surg. 2019;81(2):103–10.
24. Winters ZE, Benson JR.Can patients with multiple
breast cancers in the same breast avoid mastectomy
by having multiple lumpectomies to achieve equivalent rates of local breast cancer recurrence? response
to the preliminary alliance 11102 trial report. Ann
Surg Oncol. 2019;26:700–1.

Overview ofBreast Reconstruction
https://t.me/medicina_free
S.V.S.Deo, JyotiSharma, ChitreshKumar,
andV.Seenu
24
24.1 Background
Breast conservation and oncoplasty may not be
possible in all the women with breast cancer
when the oncological safety is at compromise or
due to patient related factors. Such women are
likely to have large, multicentric or hereditary
breast cancers. Breast aesthetics can still be
maintained in these women with breast reconstruction. Breast reconstruction has evolved over
last 3 decades and involves various types of
autologous ap reconstruction methods and
implant based breast reconstruction
24.2 Denition
Breast reconstruction is a surgical procedure that
restores shape to breast after mastectomy done to
treat or prevent breast cancer [1].
S. V. S. Deo (*) · J. Sharma
DR BRAIRCH, All India Institute of Medical
Sciences, New Delhi, India
C. Kumar
Department of Surgical Oncology, DR BRA-IRCH,
AIIMS, New Delhi, India
V. Seenu
Department of Surgery, AIIMS, New Delhi, India
24.3 Classication
1. Based on composition: The breast can be
reconstructed using alloplastic or autologous
tissue. Sometimes combined reconstruction
may be needed. Alloplastic reconstruction
involves placement of saline or silicone gel
lled implants. Autologous reconstruction
uses the patient’s own skin, fat, and muscle to
reconstruct the breast mound. Broadly, it is
divided into pedicled versus free ap [2].
2. Based on indications: Mostly breast recon-
struction is therapeutic but sometimes in
hereditary cases, prophylactic contralateral or
bilateral reconstruction is being performed
3. Based on timing: It can be immediate recon-
struction following mastectomy or delayed
reconstruction afterwards. There is little evidence available from randomized studies to
favor immediate or delayed reconstruction
Immediate reconstruction is associated with
low cost, lesser anesthesia related complications,
improved psychological benet and better cosmetic outcome. Mostly implants are used in
immediate reconstruction. Delayed reconstruction might be offered to patients with advanced
disease, with uncertainties about disease control,
or patients not able to decide for reconstruction at
the time of their oncologic procedure. Commonly
delayed autologous reconstruction is preferred
when adjuvant radiation therapy is expected, to
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_24
179

180
https://t.me/medicina_free
S. V. S. Deo et al.
avoid complication related to tissue expander or
implant. Breast implants may have capsular rupture or contracture (tightening or hardening of
the scar tissue around the implant) and need revision surgeries. Therefore we should wait for
6months to a year to decrease the risk of complications. Delayed breast reconstruction is, however, considered more challenging than
immediate reconstruction due to post-radiation
skin and soft tissue changes
There is another two-stage approach,
“delayed-immediate breast reconstruction,” for
patients who are at an increased risk for factors
necessitating post mastectomy radiotherapy. It
allows patients who do not require radiotherapy
to receive the benets of skin-sparing mastectomy with aesthetic outcomes similar to those of
immediate reconstruction. Patients who do
require radiation receive a skin-preserving
delayed reconstruction, while avoiding the problems that can be associated with radiation delivery after an immediate breast reconstruction [3].
24.4 Components
1. Mound: Shape and volume
2. Nipple-areola complex
3. Symmetry
24.5 Techniques
There are many ways for breast reconstruction
but following are the most commonly used
1. Tissue Expander– Breast implants: This is
the most common two-stage technique used
worldwide. The mastectomy prior to TEbreast reconstruction can be either a simple
skin-sparing or skin reducing or NAC-sparing
mastectomy. A tissue expander, a temporary
silastic implant, is inserted in to a partial or
complete pocket created beneath the pectoralis major muscle. For submuscular pocket creation, the pectoralis major is dissected from
its insertion on the rib cage, starting with the
lateral edge. The acellular human or animal
dermal onlay grafts or polyester mesh have
been used as “pectoralis extender,” covering
the inferolateral portion of the TE.The saline
solution is injected into a tube inside of the
expander, which allows for the expansion of
the tissue until the tissue is stretched to the
appropriate size. Tissue expansion is normally
started from the 10th to the 14th postoperative
day as outpatient expansion, and is usually
repeated every 1–4 weeks according to the
patient will. The desired expansion is usually
achieved by 2months. However, second stage
reconstruction with exchange to nal implant
usually takes place after 6months [4].
2. Direct to implant– This involves placement
of nal implant at the time of mastectomy. It
mandates healthy native skin during surgery
and is suitable for small to medium breast
with minimal ptosis. Patient might need second surgery (for contouring, symmetry, or
nipple reconstruction)
3. Flap reconstruction: The second most com-
mon procedure uses tissue from other parts of
the patient’s body, such as the back, buttocks,
thigh or abdomen. This procedure may be performed by leaving the donor tissue connected
to the original site to retain its blood supply
(the vessels are tunneled beneath the skin surface to the new site: pedicled aps) or it may
be cut off and new blood supply may be connected (free aps). Few commonly performed
aps are described in subsequent chapters of
this book
4. Nipple and areola reconstruction: Aim is to
create a nipple and areola that mimics the
native papule in size, position, projection,
color, and texture. Nipple reconstruction is the
nal step and usually delayed for 3–5months
until after the breast mound reconstruction is
completed so that the positioning can be
planned precisely. Procedure includes reconstruction of the projecting nipple and pigmentation. Pigmentation of the NAC can be
obtained via tattoo or skin graft. There are
several methods of reconstructing the nippleareolar complex [5].

24 Overview ofBreast Reconstruction
https://t.me/medicina_free
181
(a) Nipple-areolar composite graft/ nipple
sharing–It is feasible when the patient
has sufciently large nipples. Partial
dome of contralateral nipple-areolar tissue is harvested and sutured to the deepithelialized recipient site [6]. Distant
site composite grafts like toe pulp, and
labial tissue were employed before. They
gave satisfactory results but donor site
morbidity made these techniques
obsolete
(b) Local tissue aps– Nipple may be cre-
ated by raising a small ap in the target
area and producing a raised mound of
skin. To create an areola, a circular incision may be made around the new nipple
and sutured back again. Among the various aps designed, C-V, S, star, skate, and
arrow aps are by far the most commonly
employed
(c) Grafts with traditional aps- Numerous
autologous, alloplastic, and allogenic
grafts have been used in combination
with aps to maintain nipple projection.
None of them is ideal and has different
complications including loss of projection [7].
Different techniques and modications of
breast and NAC reconstruction are described in
literature. Few commonly performed procedures
will be described in detail in the subsequent
chapters
24.6 Key Points
The reader should be able to decide the ideal candidates for breast reconstruction and the technique of mound reconstruction suitable for an
individual patient. Nipple areolar complex reconstruction is an important nal component
References
1. Platt J, Baxter NN, McLaughlin J, Semple JL. Does
breast reconstruction after mastectomy for breast cancer affect overall survival? Long-term follow-up of a
retrospective population-based cohort. Plast Reconstr
Surg. 2015;135:468e–76e.
2. Somogyi RB, Ziolkowski N, Osman F, Ginty A,
Brown M. Breast reconstruction: updated overview
for primary care physicians. Can Fam Physician.
2018;64(6):424–32.
3. Kronowitz SJ. Delayed-immediate breast reconstruction: technical and timing considerations. Plast
Reconstr Surg. 2010 Feb;125(2):463–74.
4. Bertozzi N, Pesce M, Santi PL, Raposio E. Tissue
expansion for breast reconstruction: methods and
techniques. Ann Med Surg. 2017;21:34–44.
5. Gougoutas AJ, Said HK, Um G, Chapin APA-C,
Mathes DW. Nipple-areola complex reconstruction.
Plast Reconstr Surg. 2018 March;141(3):404e–16e.
6. Lee TJ, Noh HJ, Kim EK, Eom JS. Reducing donor
site morbidity when reconstructing the nipple
using a composite nipple graft. Arch Plast Surg.
2012;39(4):384–9.
7. Bertozzi N, Simonacci F, Pesce M, Santi PL, Raposio
E.Nipple reconstruction techniques: which is the best
choice? Open Med J. 2018;5(1):62–75.

Skin Sparing Mastectomy
https://t.me/medicina_free
andNipple Areola Sparing
Mastectomy
S.V.S.Deo andS.ManojGowda
25
25.1 Introduction
The eld of breast surgery has signicantly
evolved over the last few decades paralleling our
improved understanding of the anatomy of the
breast and disease biology. Conservative mastectomies followed by immediate breast reconstruction have emerged as oncologically safe options
yielding excellent cosmetic outcomes [1]. In
addition, the introduction of genetic testing and
risk reducing surgeries has expanded this eld
further in the recent past.
Conservative mastectomies incorporate the
advantage of complete excision of tumour and
breast tissue, as in traditional total mastectomy,
with improvement in aesthetic outcome through
conservation of skin and nipple areola complex
(NAC). Conventional modied radical mastectomy is usually performed with an elliptical
incision incorporating NAC and liberal amount
of skin. In patients undergoing mastectomy
without reconstruction the aim is to remove all
redundant skin and leave chest wall as at as
possible. By contrast in patients planned for
conservative mastectomy with immediate recon-
S. V. S. Deo (*)
Department of Surgical Oncology, AIIMS and NCI,
New Delhi, India
S. ManojGowda
Department of Surgical Oncology, AIIMS,
New Delhi, India
struction, NAC and as much skin as possible
should be preserved with natural anatomical
boundaries to improve aesthetic outcomes following primary implant or autologous breast
reconstruction.
25.2 Oncological Concepts
ofConservative Mastectomy
(i) Rationale for removing Skin and NAC
during standard Mastectomy:
(a) The rationale for removing the NAC as
part of therapeutic mastectomy is due to
concern that the cancer may be present
in the NAC or the cancer may form de
novo in breast tissue retained with in the
NAC.
(b) Rationale for removing the skin over the
tumour is to prevent any chance of leaving behind the breast tissue harbouring
tumour cells.
(ii) Oncological considerations in Conserva-
tive Mastectomies:
It should be noted that a well conducted
conservative mastectomy (CM), will remove
all the breast tissue including the tissue present behind the NAC complex. In a properly
selected case, the local recurrence rate of
conservative mastectomy equals to that of
the modied radical mastectomy [1].
However, cases with extension of tumour
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_25
183

184
https://t.me/medicina_free
S. V. S. Deo and S. ManojGowda
into the skin and NAC should be carefully
excluded from conservative mastectomy
group.
25.3 Conservative Mastectomy
CM incorporates removal of entire breast parenchyma, sparing skin or in selected cases
NAC.Three techniques of CM are described:
1. Skin sparing mastectomy (SSM),
2. Nipple sparing mastectomy (NSM), and
3. Skin reducing mastectomy (SRM)
25.4 Surgical Anatomy Pertaining
toConservative Mastectomy
Mammary gland is located in between the anterior lamina (premammary layer) and posterior
lamina (retromammary layer) of supercial facia.
External to anterior lamina, there is celluloadipose layer, which varies in thickness from person to person. Below the lamina there are large
axial vessels from where vertical branches branch
off towards the subdermal plexus. Cooper’s ligament pass from anterior surface of mammary
gland to the supercial lamina. Anatomical borders of mammary gland are:
25.5 Patient Selection
forConservative
Mastectomy
1. SSM
Indications Contraindications
1. Extensive ductal
carcinoma in situ
(DCIS) with nipple
discharge/DCIS close to
nipple
2. Multifocal/multicentric
early breast cancer
3. Positive retro areolar
frozen section during
NSM
2. NSM
Indications Contraindications
1. Tumour related factors:
(a) Extensive DCIS
(b) Multifocal/
Multicenteric early
breast cancer
(c) Breast conservation
surgery (BCS)
leading to predicted
bad cosmesis
2. Patient related factors:
(a) Risk reducing
mastectomy
(BRCA1/2 carriers)
(b) Patient refuses BCS
(c) Contraindication to
radiotherapy
1. Locally advanced
breast cancer/
inammatory
carcinoma
2. Smoking (relative
contraindication)
1. Absolute:
(a) Locally advanced
breast cancer/
inammatory
carcinoma
(b) NAC involvement
(c) Paget’s disease of
nipple
(d) Tumour<2cm
from nipple
2. Relative:
(a) Previous RT,
smoking, DM
(b) Large Ptotic
breast
1. Superior: Large infraclavicular muscle
bundle
2. Medial: Mid sternal line
3. Lateral: Front edge of latissimus dorsi
4. Inferior: Lower edge of pectoralis major on 6th
rib. This border is important due to the presence
of inframammary fold, an area where supercial facia joins the deep pectoralis fascia.
Arterial supply of NAC is by the subareolar
plexus formed by perforating branches of four
arteries: Internal mammary artery, external mammary artery, anterior medial intercostal perforators, and anterior lateral intercostal perforators.
Venous outow is through perforating veins of
internal mammary, intercostal veins and axillary
veins. Detailed anatomy is described elsewhere
in the book.
25.6 Skin Sparing Mastectomy
(SSM)
SSM was rst described by Toth, Lappert, and
Kroll in 1991 [2]. SSM involves the removal of
entire breast tissue, saving the breast skin and
removal of the NAC and any area with previous
surgical biopsy incisions.
Classication of SSM Carlson classied SSM
in 1997 based on surgical approach and previous
biopsy scar if any (Fig.25.1) [3]:
1. Type 1 SSM: Only NAC removed. Peri-
areolar incision is used. Commonly indicated
in prophylactic mastectomy and for nonpalpable cancers. In patients with small diameter areola, a lateral extension or tennis

Type IType II
ab
cd
25 Skin Sparing Mastectomy andNipple Areola Sparing Mastectomy
https://t.me/medicina_free
racquet incision is used to improve exposure
(Fig.25.2).
2. Type 2 SSM: Used when a supercial tumour
or previous surgery scar is in proximity to
areola. NAC, skin overlying supercial
tumours and previous biopsy incision are
removed in continuity with NAC.
3. Type 3 SSM: Used when a supercial tumour
or previous incision is remote from the areola.
Type III Type IV
NAC, skin overlying supercial tumours and
previous biopsy incision removed without
intervening skin. Care must be taken to ensure
the viability of intervening skin.
4. Type 4 SSM: NAC removed with an inverted
or reduction pattern skin incision. Used in
large ptotic breasts when a reduction is
planned on opposite breast.
Fig. 25.1 Carlson classication of types of SSM
185
Fig. 25.2 (a) Preoperative image of a patient with multicentric DCIS in left breast (b) Skin sparing mastectomy with
tennis racquet incision (c) marking for extended LD ap recon (d) Final outcome after LD ap reconstruction

186
ab
cd
https://t.me/medicina_free
S. V. S. Deo and S. ManojGowda
25.7 Nipple Sparing Mastectomy
(NSM)
NSM involves removal of all breast tissue while
preserving the skin of breast, NAC, and inframammary fold.
Incisions: Seven basic types of incisions are
used for NSM (Fig.25.3).
(a) Skin sparing dissection of nipple skin as a
free graft with dissection and removal of
nipple duct tissue.
Fig. 25.3 Various incisions for NSM (Left breast). (a)
Peri-areolar incision, (b) Upper peri-areolar, (c) Upper
peri-areolar with lateral extension, (d) Lower peri-areolar
with inferior extension, (e) Trans nipple, (f) Trans areolar,
(g) Inframammary, (h) Batwing incision
Соседние файлы в папке Библиотека им академика М.И. Перельмана
